Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1H2 | P55055 | 14/20 | 0.54 |
| ▸ | NR1H3 | Q13133 | 14/20 | 0.54 |
| ▸ | MLYCD | O95822 | 2/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL131990 | 0.84 | NR1H2 (0.68) | NR1H2NR1H3MLYCDSMN1; SMN2 | |
| SCHEMBL7131226 | 0.82 | MLYCD (0.56) | NR1H2NR1H3MLYCDSMN1; SMN2 | |
| SCHEMBL24901417 | 0.82 | NR1H2 (0.50) | NR1H2NR1H3MLYCDSMN1; SMN2 | |
| Water SCHEMBL1684070 | 0.82 | NR1H2 (0.65) | NR1H2NR1H3MLYCDSMN1; SMN2 | |
| SCHEMBL9621271 | 0.77 | NR1H2 (0.60) | NR1H2NR1H3MLYCDSMN1; SMN2 | |
| SCHEMBL24901413 | 0.77 | NR1H2 (0.61) | NR1H2NR1H3MLYCDSMN1; SMN2 | |
| SCHEMBL13374679 | 0.77 | NR1H2 (0.51) | NR1H2NR1H3MLYCDSMN1; SMN2 | |
| SCHEMBL28365026 | 0.76 | KIF11 (0.64) | NR1H2NR1H3MLYCDSMN1; SMN2 | |
| SCHEMBL1516045 | 0.75 | ESR1 (0.61) | NR1H2NR1H3MLYCDSMN1; SMN2 | |
| SCHEMBL8021367 | 0.75 | NR1H2 (0.58) | NR1H2NR1H3MLYCDSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250368595-A1 | NOVEL MOLECULES | Xeniopro GmbH (DE) | 2025-12-04 | — | — | US | claimed |
| US-20250368595-A1 | NOVEL MOLECULES | Xeniopro GmbH (DE) | 2025-12-04 | — | — | US | disclosed |
| US-20230141913-A2 | PHENOXY(HETERO)ARYL ETHERS OF ANTIPROLIFERACTIVE ACTIVITY | Xeniopro GmbH (DE) | 2023-05-11 | — | — | US | disclosed |
| US-20220249500-A1 | PHENOXY(HETERO)ARYL ETHERS OF ANTIPROLIFERACTIVE ACTIVITY | Xeniopro GmbH (DE) | 2022-08-11 | — | — | US | disclosed |
| US-10363740-B2 | Liquid ejection head and method for manufacturing the same | CANON KABUSHIKI KAISHA (JP) | 2019-07-30 | — | — | US | disclosed |
| US-20180201018-A1 | LIQUID EJECTION HEAD AND METHOD FOR MANUFACTURING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2018-07-19 | — | — | US | disclosed |
| US-20180201018-A1 | LIQUID EJECTION HEAD AND METHOD FOR MANUFACTURING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2018-07-19 | — | — | US | disclosed |
| EP-1766473-B1 | CATIONIC PHOTOPOLYMERIZABLE EPOXY RESIN COMPOSITION, MINUTE STRUCTURAL MEMBER USING THE SAME AND METHOD FOR MANUFACTURING MINUTE STRUCTURAL MEMBER | CANON KK (JP) | 2015-09-09 | — | — | EP | disclosed |
| US-7575851-B2 | Cationic photopolymerizable epoxy resin composition, minute structural member using the same and method for manufacturing minute structural member | CANON KABUSHIKI KAISHA (JP) | 2009-08-18 | — | — | US | disclosed |
| US-7553544-B2 | Precursor composition for optical resin, resin for optical use, optical element, and optical article | NIKON CORPORATION (JP) | 2009-06-30 | — | — | US | disclosed |
| US-7553544-B2 | Precursor composition for optical resin, resin for optical use, optical element, and optical article | NIKON CORPORATION (JP) | 2009-06-30 | — | — | US | disclosed |
| US-20080008971-A1 | Cationic Photopolymerizable Epoxy Resin Composition, Minute Structural Member Using the Same and Method for Manufacturing Minute Structural Member | CANON KABUSHIKI KAISHA (JP) | 2008-01-10 | — | — | US | disclosed |
| EP-0317883-B1 | PARTIALLY FLUORINATED DIPHENYL ETHERS, PROCESS FOR THEIR PREPARATION AND THEIR USE | HOECHST AKTIENGESELLSCHAFT (DE) | 1993-06-16 | — | — | EP | disclosed |
| US-4992593-A | Partially fluorinated diphenyl ethers, processes for their preparation and their use | HOECHST AKTIENGESELLSCHAFT (DE) | 1991-02-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220249500-A1 | PHENOXY(HETERO)ARYL ETHERS OF ANTIPROLIFERACTIVE ACTIVITY | AHR, MUSK, TYR | NR1H2 1555/4885NR1H3 1622/4885MLYCD 2363/4885 |
| US-20250368595-A1 | NOVEL MOLECULES | MUSK, IKZF3, TYR | NR1H2 2979/4885NR1H3 3140/4885MLYCD 2073/4885 |
| US-20230141913-A2 | PHENOXY(HETERO)ARYL ETHERS OF ANTIPROLIFERACTIVE ACTIVITY | AHR, MUSK, TYR | NR1H2 1555/4885NR1H3 1622/4885MLYCD 2363/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.